Rationale for Using Steroids in Acute Exacerbation of COPD
Mechanisms of Action and Benefits
- Systemic corticosteroids are recommended in acute exacerbations of COPD because they improve lung function, shorten recovery time, reduce risk of treatment failure, and decrease hospitalization duration, according to the American Thoracic Society 1
- Corticosteroids reduce airway inflammation, which is a key pathophysiological component of COPD exacerbations, as stated by the American College of Chest Physicians 2
- They specifically reduce lymphocytic inflammation in COPD airways, with potentially more pronounced effects in patients with predominant lymphocytic airway inflammation, as stated by the American College of Chest Physicians 2
- Systemic corticosteroids improve oxygenation during acute exacerbations, contributing to faster clinical improvement, according to the American Thoracic Society 1
Clinical Outcomes
- Systemic corticosteroids reduce the risk of early relapse following an acute exacerbation, according to the American Thoracic Society 1
Dosing and Administration
- A dose of 40 mg prednisone per day for 5 days is the recommended regimen for acute COPD exacerbations, according to the American Thoracic Society 1
- Oral administration is equally effective as intravenous administration, making oral therapy the preferred route when possible, according to the American Thoracic Society 1
Important Considerations and Caveats
- Corticosteroids may be more effective in exacerbations associated with increased sputum or blood eosinophils, according to the American Thoracic Society 1
- Short-term use of systemic corticosteroids carries risks including hyperglycemia, weight gain, and insomnia, as stated by the American College of Chest Physicians 3
- Systemic corticosteroids are only recommended for the acute treatment period and should not be continued long-term solely to prevent future exacerbations beyond the first 30 days, as stated by the American College of Chest Physicians 3